companydata.dkcompanydata.dk

AVP BioPharma Consult ApS: Financial statements 2021

CVR: 37770426

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,201,153 and a net result of DKK 260,721 compared with DKK 189,764 the year before. That is an increase of 8.5% compared with the year before. Equity in the 2021 report amounted to DKK 345,697. The solvency ratio was 66.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,201,153
Profit/Loss
DKK 260,721
Equity
DKK 345,697
Total Assets
DKK 516,443
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.2M261K346K1
2020-1.1M190K295K1
2019-1.5M320K375K1
2018-1M71K126K1
2017-1.1M58K142K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like AVP BioPharma Consult ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

AVP BioPharma Consult ApS: The 2020 annual report is outFeb 24, 2021

AVP BioPharma Consult ApS has published its annual report for 2020. Gross profit came to DKK 1,106,641, and the net result was DKK 189,764.

About AVP BioPharma Consult ApS

AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.

Source: annual report 2025, Danish Business Authority